Skip to content
How It Works
Explore
Ask a Question Resources Pricing
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 24 peer-reviewed journal articles Updated
Peripheral Artery Disease

Understanding Your PAD Diagnosis

At a Glance

A PAD diagnosis means plaque has narrowed or blocked arteries supplying your legs and may affect circulation elsewhere. It raises heart attack and stroke risk even without leg pain, so controlling smoking, cholesterol, blood pressure, and diabetes is important.

A diagnosis of Peripheral Artery Disease (PAD) means that the arteries supplying blood to your legs have become narrowed or blocked by a buildup of fatty deposits [1][2]. While the name focuses on your legs, this diagnosis is actually a window into the health of your entire circulatory system. PAD is more than just a leg problem; it is a clear signal that the process of atherosclerosis (hardening of the arteries) is active in your body [1][3].

A Common Global Health Challenge

If you have just been diagnosed, you are not alone. PAD is a widespread condition estimated to affect more than 230 million people worldwide [4][5]. It becomes significantly more common as we age, with estimates suggesting it affects up to 20% of people over the age of 80 [6][7].

Two of the most significant factors that accelerate PAD are smoking and diabetes, though high blood pressure, abnormal cholesterol, and chronic kidney disease also play major roles [8][9].

  • Smoking damages the lining of your arteries and triggers inflammation, which speeds up the development of blockages [10].
  • Diabetes causes high blood sugar that damages the delicate endothelium (the inner lining of the blood vessels) and can lead to more severe blockages below the knee [8][11].

The Mechanism: Why Blockages Form

The underlying cause of PAD is atherosclerosis, a complex biological process that happens over many years. It isn’t just a simple “clogged pipe”; it involves active changes in your biology:

  1. Endothelial Dysfunction: The inner lining of your arteries becomes damaged by factors like high blood pressure, smoking, or high cholesterol [12][10].
  2. Plaque Buildup: Cholesterol and fats from your blood seep into the damaged lining. Your immune system tries to “clean up” these fats, which creates inflammation and leads to the formation of plaque (a waxy substance made of fat and calcium) [10][13].
  3. Narrowing and Stiffness: As plaque grows, the artery becomes narrower and stiffer, making it harder for oxygen-rich blood to reach your leg muscles [12][10].
  4. Thrombosis: In some cases, a plaque can rupture or a blood clot (thrombosis) can form on the surface, suddenly cutting off blood flow [14][15].

Why PAD is a “Systemic” Disease

Doctors view PAD as a systemic disease because the factors causing blockages in your legs are likely affecting your heart and brain as well [1][3].

When you are diagnosed with PAD, you have an established risk for Major Adverse Cardiovascular Events (MACE), such as heart attacks and strokes [16][1]. In fact, research shows that people with PAD who have no leg symptoms at all still face nearly double the risk of cardiovascular-related death compared to those without the disease [17][2]. This does not mean you automatically need coronary stress testing or carotid imaging without related symptoms, but it does mean your medical team will focus intensively on protecting your heart through risk-factor management like statins and blood pressure control [18][19].

Misunderstandings About Symptoms

One of the most dangerous myths about PAD is that you must have leg pain to have the disease. In reality, the “classic” symptom—known as intermittent claudication (cramping pain in the calf that starts with walking and stops with rest)—is estimated to be present in only about 10% to 35% of patients [2][20].

The vast majority of people with PAD fall into these categories:

  • Asymptomatic: An estimated 20% to 50% of people have no noticeable leg symptoms at all [2].
  • Atypical Symptoms: Roughly 40% to 50% have symptoms that don’t fit the classic “cramp-and-rest” pattern. They may feel leg heaviness, fatigue, weakness, or an “aching” that doesn’t always stop immediately when they sit down [2][20].

Because symptoms are often subtle, PAD can go undiagnosed for years. Women, in particular, are more likely to experience these atypical symptoms, which can lead to delays in diagnosis [21][22].

The Spectrum of PAD

PAD is a condition that is generally viewed as a spectrum:

  • Asymptomatic PAD: The arteries are narrowed, but you don’t feel it yet. However, the risk to your heart is still elevated [1][17].
  • Intermittent Claudication: Walking causes predictable muscle pain because the narrowed arteries can’t keep up with the demand for oxygen [23][2].
  • Chronic Limb-Threatening Ischemia (CLTI): This is a severe clinical syndrome, where blood flow is so low that you have pain even while resting, or you develop non-healing sores and ulcers on your feet [23][24].

Understanding where you are on this spectrum is the first step in working with your doctor to stabilize the disease and protect your mobility.

Common questions in this guide

What does a peripheral artery disease diagnosis mean?
It means fatty deposits have narrowed or blocked arteries that carry blood to your legs. PAD is also a sign of atherosclerosis, or artery hardening, elsewhere in the body and is linked with a higher risk of heart attack and stroke.
Can I have PAD without classic calf pain?
Yes. Many people have no noticeable leg symptoms, while others experience heaviness, fatigue, weakness, or aching instead of predictable calf cramps. Tell your healthcare team about changes in walking ability or the appearance and temperature of your feet.
What is intermittent claudication?
Intermittent claudication is cramping or aching in a leg muscle, often the calf, that starts with walking and improves with rest. It is the classic PAD symptom, but it occurs in only a minority of people with PAD.
What symptoms can indicate severe PAD?
Pain in the feet or legs while resting, or sores and ulcers on the feet that do not heal, can indicate chronic limb-threatening ischemia, a severe form of PAD caused by very low blood flow. These changes need prompt medical assessment.
Which conditions and habits can make PAD worse?
Smoking injures the artery lining and promotes inflammation, while diabetes can damage blood vessels and contribute to more severe blockages. High blood pressure, abnormal cholesterol, chronic kidney disease, and older age are also associated with PAD risk.
Does a PAD diagnosis mean I need heart or carotid artery tests?
Not automatically. Without related symptoms, a PAD diagnosis does not by itself mean you need coronary stress testing or carotid imaging; your healthcare team will focus on controlling risks such as cholesterol and blood pressure. Ask which tests are appropriate for your symptoms and overall risk.
What does the ankle-brachial index tell me?
The ankle-brachial index, or ABI, compares blood pressure at your ankle with pressure in your arm to help assess blood flow to your legs. Ask how your result should be interpreted, especially if you have diabetes, and what cholesterol and blood pressure targets are right for you.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.What is my current ankle-brachial index (ABI), and does it accurately reflect the health of my arteries if I have diabetes?
  2. 2.Since PAD is a systemic disease, what steps should we take to assess and aggressively manage my cardiovascular risk?
  3. 3.If I don't have 'classic' calf pain, what specific leg symptoms or physical changes should I be monitoring for?
  4. 4.What are my target numbers for LDL cholesterol and blood pressure now that I have a PAD diagnosis?
  5. 5.Do my current symptoms warrant any additional cardiovascular testing, or is aggressive risk-factor management the priority?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (24)
  1. 1

    2024 ACC/AHA/AACVPR/APMA/ABC/SCAI/SVM/SVN/SVS/SIR/VESS Guideline for the Management of Lower Extremity Peripheral Artery Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.

    , Gornik HL, Aronow HD, et al.

    Journal of the American College of Cardiology 2024; (83(24)):2497-2604 doi:10.1016/j.jacc.2024.02.013.

    PMID: 38752899
  2. 2

    Lower Extremity Peripheral Artery Disease Without Chronic Limb-Threatening Ischemia: A Review.

    Polonsky TS, McDermott MM

    JAMA 2021; (325(21)):2188-2198 doi:10.1001/jama.2021.2126.

    PMID: 34061140
  3. 3

    Lower extremity arterial disease perspective: IUA consensus document on "lead management". Part 1.

    Antignani PL, Gargiulo M, Gastaldi G, et al.

    International angiology : a journal of the International Union of Angiology 2023; (42(5)):382-395 doi:10.23736/S0392-9590.23.05110-6.

    PMID: 37822195
  4. 4

    Trends and Potential Risk Factors of Lower Extremity Peripheral Arterial Disease: Results from the Global Burden of Disease Study 2021.

    Zhang B, Zhang H, Gong H, Ge J

    Pulse (Basel, Switzerland) 2025; (13(1)):140-156 doi:10.1159/000547795.

    PMID: 41246568
  5. 5

    Global, regional, and national prevalence and risk factors for peripheral artery disease in 2015: an updated systematic review and analysis.

    Song P, Rudan D, Zhu Y, et al.

    The Lancet. Global health 2019; (7(8)):e1020-e1030 doi:10.1016/S2214-109X(19)30255-4.

    PMID: 31303293
  6. 6

    Global burden of peripheral artery disease and its risk factors, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019.

    The Lancet. Global health 2023; (11(10)):e1553-e1565 doi:10.1016/S2214-109X(23)00355-8.

    PMID: 37734799
  7. 7

    Epidemiology of peripheral artery disease.

    Criqui MH, Aboyans V

    Circulation research 2015; (116(9)):1509-26 doi:10.1161/CIRCRESAHA.116.303849.

    PMID: 25908725
  8. 8

    Molecular complexities underlying the vascular complications of diabetes mellitus - A comprehensive review.

    Paul S, Ali A, Katare R

    Journal of diabetes and its complications 2020; (34(8)):107613 doi:10.1016/j.jdiacomp.2020.107613.

    PMID: 32505477
  9. 9

    Regulation of endothelial function by cigarette smoke and next-generation tobacco and nicotine products.

    Klein J, Diaba-Nuhoho P, Giebe S, et al.

    Pflugers Archiv : European journal of physiology 2023; (475(7)):835-844 doi:10.1007/s00424-023-02824-w.

    PMID: 37285061
  10. 10

    Smoking and the Pathophysiology of Peripheral Artery Disease.

    Wang W, Zhao T, Geng K, et al.

    Frontiers in cardiovascular medicine 2021; (8()):704106 doi:10.3389/fcvm.2021.704106.

    PMID: 34513948
  11. 11

    Peripheral Artery Disease in Diabetes Mellitus: Focus on Novel Treatment Options.

    Demarchi A, Somaschini A, Cornara S, Androulakis E

    Current pharmaceutical design 2020; (26(46)):5953-5968 doi:10.2174/1389201021666201126143217.

    PMID: 33243109
  12. 12

    Oxidative Stress and Arterial Dysfunction in Peripheral Artery Disease.

    Ismaeel A, Brumberg RS, Kirk JS, et al.

    Antioxidants (Basel, Switzerland) 2018; (7(10)) doi:10.3390/antiox7100145.

    PMID: 30347720
  13. 13

    The Role of the Coagulation System in Peripheral Arterial Disease: Interactions with the Arterial Wall and Its Vascular Microenvironment and Implications for Rational Therapies.

    Miceli G, Basso MG, Rizzo G, et al.

    International journal of molecular sciences 2022; (23(23)) doi:10.3390/ijms232314914.

    PMID: 36499242
  14. 14

    Pathology of Peripheral Artery Disease in Patients With Critical Limb Ischemia.

    Narula N, Dannenberg AJ, Olin JW, et al.

    Journal of the American College of Cardiology 2018; (72(18)):2152-2163 doi:10.1016/j.jacc.2018.08.002.

    PMID: 30166084
  15. 15

    Pathologic Disparities Between Peripheral Artery Disease and Coronary Artery Disease.

    Narula N, Olin JW, Narula N

    Arteriosclerosis, thrombosis, and vascular biology 2020; (40(9)):1982-1989 doi:10.1161/ATVBAHA.119.312864.

    PMID: 32673526
  16. 16

    Rivaroxaban and Aspirin in Patients With Symptomatic Lower Extremity Peripheral Artery Disease: A Subanalysis of the COMPASS Randomized Clinical Trial.

    Kaplovitch E, Eikelboom JW, Dyal L, et al.

    JAMA cardiology 2021; (6(1)):21-29 doi:10.1001/jamacardio.2020.4390.

    PMID: 32997098
  17. 17

    Cardiovascular long-term outcome and prophylactic treatment patterns in peripheral arterial disease in a population-based cohort.

    Sartipy F, Lundin F, Wahlberg E, Sigvant B

    European heart journal. Quality of care & clinical outcomes 2019; (5(4)):310-320 doi:10.1093/ehjqcco/qcz037.

    PMID: 31304962
  18. 18

    [Conservative treatment of peripheral arterial disease].

    Espinola-Klein C, Weißer G

    Innere Medizin (Heidelberg, Germany) 2022; (63(6)):579-583 doi:10.1007/s00108-022-01342-8.

    PMID: 35532800
  19. 19

    Low-Density Lipoprotein Cholesterol Lowering With Evolocumab and Outcomes in Patients With Peripheral Artery Disease: Insights From the FOURIER Trial (Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk).

    Bonaca MP, Nault P, Giugliano RP, et al.

    Circulation 2018; (137(4)):338-350 doi:10.1161/CIRCULATIONAHA.117.032235.

    PMID: 29133605
  20. 20

    Lower extremity manifestations of peripheral artery disease: the pathophysiologic and functional implications of leg ischemia.

    McDermott MM

    Circulation research 2015; (116(9)):1540-50 doi:10.1161/CIRCRESAHA.114.303517.

    PMID: 25908727
  21. 21

    Differences in Symptom Presentation in Women and Men with Confirmed Lower Limb Peripheral Artery Disease: A Systematic Review and Meta-Analysis.

    Porras CP, Bots ML, Teraa M, et al.

    European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery 2022; (63(4)):602-612 doi:10.1016/j.ejvs.2021.12.039.

    PMID: 35248439
  22. 22

    Management of Peripheral Artery Disease in Adults With Diabetes: 2025 ACC Scientific Statement: A Report of the American College of Cardiology.

    Das SR, Bonaca MP, Creager MA, et al.

    Journal of the American College of Cardiology 2025; doi:10.1016/j.jacc.2025.11.027.

    PMID: 41405527
  23. 23

    2024 ACC/AHA/AACVPR/APMA/ABC/SCAI/SVM/SVN/SVS/SIR/VESS Guideline for the Management of Lower Extremity Peripheral Artery Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.

    Gornik HL, Aronow HD, Goodney PP, et al.

    Circulation 2024; (149(24)):e1313-e1410 doi:10.1161/CIR.0000000000001251.

    PMID: 38743805
  24. 24

    Diabetes Mellitus and Lower Extremity Peripheral Artery Disease.

    Takahara M

    JMA journal 2021; (4(3)):225-231 doi:10.31662/jmaj.2021-0042.

    PMID: 34414316

This page explains what a PAD diagnosis can mean for your symptoms and cardiovascular risk for informational purposes only; it does not constitute medical advice. Ask your healthcare team to interpret your ABI and set appropriate cholesterol and blood pressure goals.

Get notified when new evidence is published on peripheral arterial disease.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.